journal article·2025-06-11

Carbazole Engineering in D–A–D Molecules to Improve the NIR-II Performance for Tumor Micrometastasis Imaging

Le Fang, Rui Ai, Maria Eugenia Sandoval-Salinas, Lei Tan, Chun Liu, Qiang Wen, Huarong Tang, Tao Zhu, Rachel Crespo-Otero, Xiaohong Fang

Nano Letters· Volume 25· Issue 23
Publisher page

Abstract

It is important to image tumor micrometastases in fluorescence-guided surgery (FGS), which requires highly emissive materials with a high signal-to-background ratio. As one type of bright NIR-II dye, donor–acceptor–donor (D–A–D) molecules have been widely applied for in vivo imaging. However, the brightness of D–A–D molecules when encapsulated in nanoparticles for bioimaging is often unsatisfactory due to aggregation-caused quenching or a decrease in absorption. In this study, we introduced carbazole groups in the D–A–D molecules, which resulted in a reduction of fluorescence quenching in the aggregated state due to the larger intermolecular distance. Through proper engineering of the carbazole groups, the emission spectra of the nanoparticles could be red-shifted with a peak beyond 1000 nm, while maintaining strong absorption and high quantum yield. The brightest TBTC-4 nanoparticles were successfully applied for tumor micrometastasis imaging in mice, with metastases as small as 0.5 mm diameter, which demonstrates their promising clinical application in FGS.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Nanoplatforms for cancer theranostics · Luminescence and Fluorescent Materials · Ga2O3 and related materials

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

National “111” Center for Cellular Regulation and Molecular Pharmaceutics, Key Laboratory of Fermentation Engineering (Ministry of Education), Hubei Key Laboratory of Industrial Microbiology, School of Life and Health Sciences

Hubei University of Technology

Hangzhou Institute of Medicine

Chinese Academy of Sciences

Department of Chemistry

University College London

Department of Physics, School of Sciences

Wuhan University of Technology

Department of Gynecological Oncology

Zhejiang Cancer Hospital

Funding

National Key Research and Development Program of China · China Postdoctoral Science Foundation · Key Research and Development Program of Zhejiang Province · National Natural Science Foundation of China · Collaborative Grant-in-Aid of the HBUT National ?111? Center for Cellular Regulation and Molecular Pharmaceutics · Natural Science Foundation of Hubei University of Technology

References (47)

Show source-provided references
1. 10.1038/s41392-020-0134-x10.1038/s41392-020-0134-x ↗
2. 10.1038/s43018-021-00181-010.1038/s43018-021-00181-0 ↗
3. 10.1038/s41571-021-00548-310.1038/s41571-021-00548-3 ↗
4. 10.1038/s44222-022-00017-110.1038/s44222-022-00017-1 ↗
5. 10.21037/gs-20-67110.21037/gs-20-671 ↗
6. 10.1016/S1470-2045(18)30448-010.1016/S1470-2045(18)30448-0 ↗
7. 10.1136/ijgc-2019-00107110.1136/ijgc-2019-001071 ↗
8. 10.1200/JCO.22.0029110.1200/JCO.22.00291 ↗
9. 10.1002/adma.20241570510.1002/adma.202415705 ↗
10. 10.1038/s41467-024-50202-610.1038/s41467-024-50202-6 ↗
11. 10.1002/anie.20240396810.1002/anie.202403968 ↗
12. 10.1021/jacs.3c1385110.1021/jacs.3c13851 ↗
13. 10.1021/acs.nanolett.4c0547010.1021/acs.nanolett.4c05470 ↗
14. 10.1002/anie.20242397810.1002/anie.202423978 ↗
15. 10.1002/anie.20211472210.1002/anie.202114722 ↗
16. 10.1002/adfm.20231081810.1002/adfm.202310818 ↗
17. 10.1038/s41467-023-40728-610.1038/s41467-023-40728-6 ↗
18. 10.1002/anie.20221537210.1002/anie.202215372 ↗
19. 10.1021/jacs.7b1033410.1021/jacs.7b10334 ↗
20. 10.1021/acs.chemmater.9b0515910.1021/acs.chemmater.9b05159 ↗
21. 10.31635/ccschem.022.20210154710.31635/ccschem.022.202101547 ↗
22. 10.1038/s41467-022-31521-y10.1038/s41467-022-31521-y ↗
23. 10.1021/jacs.0c0818710.1021/jacs.0c08187 ↗
24. 10.1021/accountsmr.0c0011410.1021/accountsmr.0c00114 ↗
25. 10.1002/adma.20160549710.1002/adma.201605497 ↗
26. 10.1038/s41467-019-09043-x10.1038/s41467-019-09043-x ↗
27. 10.1002/adma.20221163210.1002/adma.202211632 ↗
28. 10.1002/adhm.20230053710.1002/adhm.202300537 ↗
29. 10.1021/jacs.0c0719310.1021/jacs.0c07193 ↗
30. 10.1002/adfm.20190812510.1002/adfm.201908125 ↗
31. 10.1021/jacs.2c0744310.1021/jacs.2c07443 ↗
32. 10.1021/acs.nanolett.3c0275110.1021/acs.nanolett.3c02751 ↗
33. 10.1002/advs.20220765110.1002/advs.202207651 ↗
34. 10.1016/j.ccr.2022.21460910.1016/j.ccr.2022.214609 ↗
35. 10.1016/j.jcis.2021.04.08110.1016/j.jcis.2021.04.081 ↗
36. 10.1039/C3MH00098B10.1039/C3MH00098B ↗
37. 10.1016/j.comptc.2015.06.01310.1016/j.comptc.2015.06.013 ↗
38. 10.1039/C6TC02009G10.1039/C6TC02009G ↗
39. 10.1002/adhm.20190147010.1002/adhm.201901470 ↗
40. 10.1093/nsr/nwaa26010.1093/nsr/nwaa260 ↗
41. 10.1002/anie.20211743610.1002/anie.202117436 ↗
42. 10.1002/adma.20180076610.1002/adma.201800766 ↗
43. 10.1002/advs.20200044110.1002/advs.202000441 ↗
44. 10.1016/j.mtbio.2020.10008710.1016/j.mtbio.2020.100087 ↗
45. 10.1002/smll.20220415310.1002/smll.202204153 ↗
46. 10.1021/acs.nanolett.3c0082910.1021/acs.nanolett.3c00829 ↗
47. 10.1021/acs.nanolett.3c0448310.1021/acs.nanolett.3c04483 ↗